Non-classical effects of vitamin D
https://doi.org/10.14341/osteo2017390-101
Abstract
Since the discovery of vitamin D, interest in role of vitamin D in human body is consistently growing, and there is increasing evidence that vitamin D is not only essential to bone health but may also be involved in physiology of many other tissues. Thus understanding of its aspects in particular tissues appears to be important because of possible contribution to pathophysiologic processes. Intracrine regulatory systems associated with widely expressed vitamin D metabolizing enzymes, ways of cellular intake and signal pathways involved are of particular interest. Association of local effects with vitamin D level in blood is under investigation on animal models as well as in clinical studies; values of vitamin D level that mediate extraskeletal effects should be determined. In this review, we discuss impact of vitamin D on immune function and its association with skin, nervous system, cardiovascular system, obesity and diabetes mellitus, cancer, reproductive function, prevention of falls and quality of life improvement.
About the Authors
Ekaterina A. PigarovaEndocrinology Research Centre
Russian Federation
M.D., PhD
Alexandra A. Petrushkina
Endocrinology Research Centre
Russian Federation
MD
References
1. Bikle Daniel D. Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & Biology. 2014;21(3):319-329. doi: 10.1016/j.chembiol.2013.12.016.
2. Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease. The Journal of Steroid Biochemistry and Molecular Biology. 2007;103(3-5):316-321. doi: 10.1016/j.jsbmb.2006.12.078.
3. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms. Best Practice & Research Clinical Endocrinology & Metabolism. 2011;25(4):543-559. doi: 10.1016/j.beem.2011.05.010.
4. Ryan JW, Anderson PH, Morris HA. Pleiotropic activities of vitamin D receptors – adequate activation for multiple health outcomes. The Clinical biochemist. Reviews. 2015;36(2):53-61. 4504155.
5. Seth-Vollenweider T, Joshi S, Dhawan P, et al. Novel mechanism of negative regulation of 1,25-dihydroxyvitamin D3-induced 25-hydroxyvitamin D3 24-Hydroxylase (Cyp24a1) transcription. Journal of Biological Chemistry. 2014;289(49):33958-33970. doi: 10.1074/jbc.M114.583302.
6. Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Science Signaling. 2009;2(75):re4-re4. doi: 10.1126/scisignal.275re4.
7. Huhtakangas JA, Olivera CJ, Bishop JE, et al. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology. 2004;18(11):2660-2671. doi: 10.1210/me.2004-0116.
8. Nemere I, Safford SE, Rohe B, et al. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. The Journal of Steroid Biochemistry and Molecular Biology. 2004;89-90:281-285. doi: 10.1016/j.jsbmb.2004.03.031.
9. Pálmer HG, González-Sancho JM, Espada J, et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. The Journal of Cell Biology. 2001;154(2):369-388. doi: 10.1083/jcb.200102028.
10. Bhan I, Powe CE, Berg AH, et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney International. 2012;82(1):84-89. doi: 10.1038/ki.2012.19.
11. Delanghe JR, Speeckaert R, Speeckaert MM. Behind the scenes of vitamin D binding protein: More than vitamin D binding. Best Practice & Research Clinical Endocrinology & Metabolism. 2015;29(5):773-786. doi: 10.1016/j.beem.2015.06.006.
12. Chun RF, Peercy BE, Orwoll ES, et al. Vitamin D and DBP: The free hormone hypothesis revisited. The Journal of Steroid Biochemistry and Molecular Biology. 2014;144:132-137. doi: 10.1016/j.jsbmb.2013.09.012.
13. Kuchiike D, Uto Y, Mukai H, et al. Degalactosylated/desialylated human serum containing GcMAF induces macrophage phagocytic activity and in vivo antitumor activity. Anticancer research. 2013;33(7):2881-2885.
14. Bikle DD, Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocrine Reviews. 1993;14(1):3-19. doi: 10.1210/edrv-14-1-3.
15. Bikle DD, Oda Y, Tu C-L, Jiang Y. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. The Journal of Steroid Biochemistry and Molecular Biology. 2015;148:47-51. doi: 10.1016/j.jsbmb.2014.10.017.
16. Komuves L, Oda Y, Tu C-l, et al. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. Journal of Cellular Physiology. 2002;192(1):45-54. doi: 10.1002/jcp.10107.
17. Bikle DD, Chang S, Crumrine D, et al. 25 hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. Journal of Investigative Dermatology. 2004;122(4):984-992. doi: 10.1111/j.0022-202X.2004.22424.x.
18. Tu C-L, Crumrine DA, Man M-Q, et al. Ablation of the calcium-sensing receptor in keratinocytes impairs epidermal differentiation and barrier function. Journal of Investigative Dermatology. 2012;132(10):2350-2359. doi: 10.1038/jid.2012.159.
19. Oda Y, Uchida Y, Moradian S, et al. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. Journal of Investigative Dermatology. 2009;129(6):1367-1378. doi: 10.1038/jid.2008.380.
20. Bikle DD, Xie Z, Tu C-L. Calcium regulation of keratinocyte differentiation. Expert Review of Endocrinology & Metabolism. 2014;7(4):461-472. doi: 10.1586/eem.12.34.
21. Bikle DD, Elalieh H, Welsh J, et al. Protective role of vitamin D signaling in skin cancer formation. The Journal of Steroid Biochemistry and Molecular Biology. 2013;136:271-279. doi: 10.1016/j.jsbmb.2012.09.021.
22. Caini S, Boniol M, Tosti G, et al. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: A comprehensive review and meta-analysis. European Journal of Cancer. 2014;50(15):2649-2658. doi: 10.1016/j.ejca.2014.06.024.
23. Hu L, Bikle DD, Oda Y. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation. The Journal of Steroid Biochemistry and Molecular Biology. 2014;144:237-241. doi: 10.1016/j.jsbmb.2013.11.002.
24. Luderer HF, Gori F, Demay MB. Lymphoid enhancer-binding factor-1 (LEF1) interacts with the DNA-binding domain of the vitamin D receptor. Journal of Biological Chemistry. 2011;286(21):18444-18451. doi: 10.1074/jbc.M110.188219.
25. Malloy PJ, Feldman D. The role of vitamin D receptor mutations in the development of alopecia. Molecular and Cellular Endocrinology. 2011;347(1-2):90-96. doi: 10.1016/j.mce.2011.05.045.
26. Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: a review. International Journal of Dermatology. 2015;54(4):383-392. doi: 10.1111/ijd.12790.
27. Kim M, Kim S-N, Lee Y, et al. Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: A systematic review and meta-analysis. Nutrients. 2016;8(12):789. doi: 10.3390/nu8120789.
28. Thacher TD. Nutritional rickets in ichthyosis and response to calcipotriene. Pediatrics. 2004;114(1):e119-e123. doi: 10.1542/peds.114.1.e119.
29. Chun RF, Liu PT, Modlin RL, et al. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Frontiers in Physiology. 2014;5. doi: 10.3389/fphys.2014.00151.
30. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. The Journal of Immunology. 2003;170(11):5382-5390. doi: 10.4049/jimmunol.170.11.5382.
31. Rolf L, Muris A-H, Hupperts R, Damoiseaux J. Vitamin D effects on B cell function in autoimmunity. Annals of the New York Academy of Sciences. 2014;1317(1):84-91. doi: 10.1111/nyas.12440.
32. Wöbke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Frontiers in Physiology. 2014;5. doi: 10.3389/fphys.2014.00244.
33. Esposito S, Lelii M. Vitamin D and respiratory tract infections in childhood. BMC Infectious Diseases. 2015;15(1). doi: 10.1186/s12879-015-1196-1.
34. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. Bmj. 2017:i6583. doi: 10.1136/bmj.i6583.
35. Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway infections: a European perspective. European Journal of Medical Research. 2016;21(1). doi: 10.1186/s40001-016-0208-y.
36. Chakhtoura M, Azar ST. The role of vitamin D deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. International Journal of Endocrinology. 2013;2013:1-10. doi: 10.1155/2013/148673.
37. Zhang J, Li W, Liu J, et al. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis. Molecular and Cellular Endocrinology. 2012;355(1):135-142. doi: 10.1016/j.mce.2012.02.003.
38. Wang J, Lv S, Chen G, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7(4):2485-2498. doi: 10.3390/nu7042485.
39. Dizdar O, Simsek Y, Cakir I, et al. Effects of vitamin D treatment on thyroid autoimmunity. Journal of Research in Medical Sciences. 2016;21(1):85. doi: 10.4103/1735-1995.192501.
40. Sadeghian M, Saneei P, Siassi F, Esmaillzadeh A. Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies. Nutrition. 2016;32(5):505-514. doi: 10.1016/j.nut.2015.11.008.
41. Yang L, Weaver V, Smith JP, et al. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn’s patients. Clinical and Translational Gastroenterology. 2013;4(4):e33. doi: 10.1038/ctg.2013.1.
42. Simpson S, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2011;82(10):1132-1141. doi: 10.1136/jnnp.2011.240432.
43. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama. 2006;296(23):2832. doi: 10.1001/jama.296.23.2832.
44. Alharbi F. Update in vitamin D and multiple sclerosis. Neurosciences. 2015;20(4):329-335. doi: 10.17712/nsj.2015.4.20150357.
45. Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. The FASEB Journal. 2014;28(6):2398-2413. doi: 10.1096/fj.13-246546.
46. Spedding S. Vitamin D and depression: A systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6(4):1501-1518. doi: 10.3390/nu6041501.
47. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128(23):2517-2531. doi: 10.1161/circulationaha.113.002654.
48. Jaimungal S, Wehmeier K, Mooradian AD, Haas MJ. The emerging evidence for vitamin D–mediated regulation of apolipoprotein A-I synthesis. Nutrition Research. 2011;31(11):805-812. doi: 10.1016/j.nutres.2011.09.005.
49. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(7):1931-1942. doi: 10.1210/jc.2011-0398.
50. Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure. JAMA Internal Medicine. 2015;175(5):745. doi: 10.1001/jamainternmed.2015.0237.
51. Rodríguez AJ, Scott D, Srikanth V, Ebeling P. Effect of vitamin D supplementation on measures of arterial stiffness: a systematic review and meta-analysis of randomized controlled trials. Clinical Endocrinology. 2016;84(5):645-657. doi: 10.1111/cen.13031.
52. Upala S, Sanguankeo A, Congrete S, Jaruvongvanich V. Effect of cholecalciferol supplementation on arterial stiffness: a systematic review and meta-analysis. Scandinavian Cardiovascular Journal. 2016;50(4):230-235. doi: 10.3109/14017431.2016.1173226.
53. Hussin AM, Ashor AW, Schoenmakers I, et al. Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials. European Journal of Nutrition. 2016;56(3):1095-1104. doi: 10.1007/s00394-016-1159-3.
54. Zaleski A, Panza G, Swales H, et al. High-dose versus low-dose vitamin D supplementation and arterial stiffness among individuals with prehypertension and vitamin D deficiency. Disease Markers. 2015;2015:1-7. doi: 10.1155/2015/918968.
55. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. Journal of the American College of Cardiology. 2011;58(2):186-192. doi: 10.1016/j.jacc.2011.02.051.
56. Witte KK, Byrom R, Gierula J, et al. Effects of vitamin D on cardiac function in patients with chronic HF. Journal of the American College of Cardiology. 2016;67(22):2593-2603. doi: 10.1016/j.jacc.2016.03.508.
57. Obi Y, Hamano T, Isaka Y. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Disease Markers. 2015;2015:1-9. doi: 10.1155/2015/868961.
58. Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Current Diabetes Reports. 2012;13(2):261-270. doi: 10.1007/s11892-012-0358-4.
59. Moukayed M, Grant W. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993-4021. doi: 10.3390/nu5103993.
60. Fleet JC, Desmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochemical Journal. 2012;441(1):61-76. doi: 10.1042/bj20110744.
61. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: An Endocrine Society scientific statement. Endocrine Reviews. 2012;33(3):456-492. doi: 10.1210/er.2012-1000.
62. Luo W, Hershberger PA, Trump DL, Johnson CS. 24-Hydroxylase in cancer: Impact on vitamin D-based anticancer therapeutics. The Journal of Steroid Biochemistry and Molecular Biology. 2013;136:252-257. doi: 10.1016/j.jsbmb.2012.09.031.
63. Bøllehuus Hansen L, Rehfeld A, de Neergaard R, et al. Selection of high-quality spermatozoa may be promoted by activated vitamin D in the woman. The Journal of Clinical Endocrinology & Metabolism. 2017;102(3):950-961. doi: 10.1210/jc.2016-3008.
64. Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Archives of Biochemistry and Biophysics. 2012;523(1):37-47. doi: 10.1016/j.abb.2011.11.018.
65. Sayegh L, Fuleihan GE-H, Nassar AH. Vitamin D in endometriosis: A causative or confounding factor? Metabolism. 2014;63(1):32-41. doi: 10.1016/j.metabol.2013.09.012.
66. Cho S, Choi YS, Yim SY, et al. Urinary vitamin D-binding protein is elevated in patients with endometriosis. Human Reproduction. 2011;27(2):515-522. doi: 10.1093/humrep/der345.
67. Jia X-Z, Wang Y-M, Zhang N, et al. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis. Journal of Obstetrics and Gynaecology Research. 2015;41(11):1791-1802. doi: 10.1111/jog.12793.
68. He C, Lin Z, Robb S, Ezeamama A. Serum vitamin D levels and polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients. 2015;7(6):4555-4577. doi: 10.3390/nu7064555.
69. Krul-Poel YHM, Snackey C, Louwers Y, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. European Journal of Endocrinology. 2013;169(6):853-865. doi: 10.1530/eje-13-0617.
70. Fang F, Ni K, Cai Y, et al. Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice. 2017;26:53-60. doi: 10.1016/j.ctcp.2016.11.008.
71. Pal L, Zhang H, Williams J, et al. Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: Secondary analysis of a multicenter randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism. 2016;101(8):3027-3035. doi: 10.1210/jc.2015-4352.
72. Principi N, Bianchini S, Baggi E, Esposito S. Implications of maternal vitamin D deficiency for the fetus, the neonate and the young infant. European Journal of Nutrition. 2012;52(3):859-867. doi: 10.1007/s00394-012-0476-4.
73. Zhou S-S, Tao Y-H, Huang K, et al. Vitamin D and risk of preterm birth: Up-to-date meta-analysis of randomized controlled trials and observational studies. Journal of Obstetrics and Gynaecology Research. 2017;43(2):247-256. doi: 10.1111/jog.13239.
74. Lu M, Xu Y, Lv L, Zhang M. Association between vitamin D status and the risk of gestational diabetes mellitus: a meta-analysis. Archives of Gynecology and Obstetrics. 2016;293(5):959-966. doi: 10.1007/s00404-016-4010-4.
75. Aghajafari F, Nagulesapillai T, Ronksley PE, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. Bmj. 2013;346(mar26 4):f1169-f1169. doi: 10.1136/bmj.f1169.
76. Wei S-Q, Qi H-P, Luo Z-C, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 2013;26(9):889-899. doi: 10.3109/14767058.2013.765849.
77. Зазерская И.Е., Шелепова Е.С., Ширинян Л.В., Кузнецова Л.В. Витамин D и гестационные риски // Остеопороз и остеопатии. – 2016. – Т. 19. – №2. – C. 48. [Zazerskaja IE, Shelepova ES, Shirinjan LV, Kuznecova L. Vitamin D i gestatsionnye riski. Osteoporosis and bone diseases. 2016;19(2):48. (In Russ.)] doi: 10.14341/osteo2016248-48.
78. Cooper C, Harvey NC, Bishop NJ, et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2016;4(5):393-402. doi: 10.1016/s2213-8587(16)00044-9.
79. Girgis CM, Clifton-Bligh RJ, Turner N, et al. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clinical Endocrinology. 2014;80(2):169-181. doi: 10.1111/cen.12368.
80. Wang Y, DeLuca HF. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152(2):354-363. doi: 10.1210/en.2010-1109.
81. Girgis CM, Mokbel N, Cha KM, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology. 2014;155(9):3227-3237. doi: 10.1210/en.2014-1016.
82. Pojednic RM, Ceglia L, Olsson K, et al. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin D receptor in human skeletal muscle cells. Calcified Tissue International. 2014;96(3):256-263. doi: 10.1007/s00223-014-9932-x.
83. Buitrago C, Pardo VG, Boland R. Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells. The Journal of Steroid Biochemistry and Molecular Biology. 2013;136:125-130. doi: 10.1016/j.jsbmb.2013.02.013.
84. Murad MH, Elamin KB, Abu Elnour NO, et al. The effect of vitamin D on falls: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10):2997-3006. doi: 10.1210/jc.2011-1193.
85. Лесняк ОМ, Никитинская ОА, Торопцова НВ, Белая ЖЕ, Белова КЮ, Бордакова ЕВ и др. Профилактика, диагностика и лечение дефицита витамина D и кальция у взрослого населения России и пациентов с остеопорозом (по материалам подготовленных клинических рекомендаций). // Научно-практическая ревматология. – 2015. – Т. 53. – №4. – С. 403–408. [Lesnyak OM, Nikitinskaya OA, Toroptsova NV, et al. The Prevention, Diagnosis, and Treatment of Vitamin D and Calcium Deficiencies in the Adult Population of Russia and in Patients with Osteoporosis (According to the Materials of Prepared Clinical Recommendations). Rheumatology Science and Practice. 2015;53(4):403. (In Russ.)] doi: 10.14412/1995-4484-2015-403-408.
86. Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е., и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых // Проблемы Эндокринологии. – 2016. – Т. 62. – №4. – C. 60-84. [Pigarova EA, Rozhinskaya LY, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84. (In Russ.)] doi: 10.14341/probl201662460-84.
Review
For citations:
Pigarova E.A., Petrushkina A.A. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101. (In Russ.) https://doi.org/10.14341/osteo2017390-101
Views:
22781
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
